IG Compliance Guide Approach To CME, Consulting Concerns PhRMA
Executive Summary
The Pharmaceutical Research & Manufacturers of America objects to the treatment of manufacturer-sponsored continuing medical education programs in the HHS Office of the Inspector General's final compliance guide
You may also be interested in...
Value-Based Contracting Needs Federal Safe Harbors To Flourish, Lilly Says
Lilly USA Deputy General Counsel Weems and former Anthem Chief Medical Officer Nussbaum offer insights on how guidance from the HHS Inspector General might help advance value-based contracting.
Sharing The Risk: Companies Turn To Multi-Sponsored Educational Programs
Pharma companies are turning to multi-sponsored continuing medical education programs as a way to mitigate risks in a climate where company-sponsored educational programs draw increased scrutiny
Sharing The Risk: Companies Turn To Multi-Sponsored Educational Programs
Pharma companies are turning to multi-sponsored continuing medical education programs as a way to mitigate risks in a climate where company-sponsored educational programs draw increased scrutiny